Active surveillance of renal masses: the role of radiology
Active surveillance of renal masses, which includes serial imaging with the possibility of
delayed treatment, has emerged as a viable alternative to immediate therapeutic …
delayed treatment, has emerged as a viable alternative to immediate therapeutic …
French AFU Cancer Committee Guidelines-update 2022-2024: management of kidney cancer
P Bigot, P Barthelemy, R Boissier, ZE Khene… - Progrès en Urologie, 2022 - Elsevier
Aim To update the recommendations for the management of kidney cancers. Methods A
systematic review of the literature was conducted from 2015 to 2022. The most relevant …
systematic review of the literature was conducted from 2015 to 2022. The most relevant …
Renal mass biopsy mandate is associated with change in treatment decisions
A Sinks, C Miller, H Holck, L Zeng, K Gaston… - The Journal of …, 2023 - auajournals.org
Purpose: To prevent avoidable treatment and make more informed care decisions about
small renal masses, the use of renal mass biopsies has increased since the early 2000s. In …
small renal masses, the use of renal mass biopsies has increased since the early 2000s. In …
Evaluation of a multiparametric renal CT algorithm for diagnosis of clear-cell renal cell carcinoma among small (≤ 4 cm) solid renal masses
F Eldihimi, C Walsh, RM Hibbert, KA Nasibi… - European …, 2024 - Springer
Objective To evaluate a recently proposed CT-based algorithm for diagnosis of clear-cell
renal cell carcinoma (ccRCC) among small (≤ 4 cm) solid renal masses diagnosed by renal …
renal cell carcinoma (ccRCC) among small (≤ 4 cm) solid renal masses diagnosed by renal …
Utility of multiparametric renal CT for differentiation of low-grade from high-grade cT1a clear cell renal cell carcinoma
JS Pickovsky, K Alo Nasiyabi, F Eldihimi… - The British Journal of …, 2023 - academic.oup.com
Objective: To determine if CT can differentiate low-grade from high-grade clear cell renal cell
carcinoma (ccRCC) in cT1a solid ccRCC. Methods and materials: This retrospective cross …
carcinoma (ccRCC) in cT1a solid ccRCC. Methods and materials: This retrospective cross …
Diagnostic Accuracy of MRI for Solid Renal Masses: A Systematic Review and Meta‐analysis
Background Biparametric (bp)‐MRI and multiparametric (mp)‐MRI may improve the
diagnostic accuracy of renal mass histology. Purpose To evaluate the available evidence on …
diagnostic accuracy of renal mass histology. Purpose To evaluate the available evidence on …
[HTML][HTML] Diagnostic Biopsy for Small Renal Tumours: A Survey of Current European Practice
Background and objective Renal tumour biopsy (RTB) can help in risk stratification of renal
tumours with implications for management, but its utilisation varies. Our objective was to …
tumours with implications for management, but its utilisation varies. Our objective was to …
Evaluation of insurance coverage and cancer stage at diagnosis among low-income adults with renal cell carcinoma after passage of the patient protection and …
JF Javier-DesLoges, J Yuan, S Soliman… - JAMA Network …, 2021 - jamanetwork.com
Importance The association of the Patient Protection and Affordable Care Act (ACA) with
insurance status and cancer stage at diagnosis among patients with renal cell carcinoma …
insurance status and cancer stage at diagnosis among patients with renal cell carcinoma …
Perspectives on the role of biopsy for management of T1 renal masses: survey results from two regional quality improvement collaboratives
Objective To understand perspectives on renal mass biopsy, a survey was distributed to
urologists in the Michigan Urological Surgery Improvement Collaborative and Pennsylvania …
urologists in the Michigan Urological Surgery Improvement Collaborative and Pennsylvania …
[HTML][HTML] Avoiding “Needless” nephrectomy: What is the role of small renal mass biopsy in 2024?
B Gao, ARH Gorgen, R Bhatt, ZE Tano… - … Oncology: Seminars and …, 2024 - Elsevier
Current guidelines do not mandate routine preoperative renal mass biopsy (RMB) for small
renal masses (SRMs), which results in a considerable rate (18%–26%) of needless …
renal masses (SRMs), which results in a considerable rate (18%–26%) of needless …